Your session is about to expire
← Back to Search
Non-Opioid Pain Management After Surgery (NOPIOiDS Trial)
N/A
Recruiting
Led By Badar Mian, MD
Research Sponsored by Albany Medical College
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
All patients undergoing major urologic cancer surgery, either open or laparoscopic, will be included in the study.
This will include all open or laparoscopic or robotic surgery including radical prostatectomy, radical cystectomy, radical nephrectomy, partial nephrectomy, nephron-ureterectomy, and similar procedures.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 30 days
Awards & highlights
NOPIOiDS Trial Summary
This trial is testing whether patients who are given a non-opioid painkiller after surgery have less pain and are less likely to use opioids later on.
Who is the study for?
This trial is for patients undergoing major urologic cancer surgeries like prostatectomy, cystectomy, or nephrectomy. It's open to those who can have surgery either through traditional (open) methods or minimally invasive techniques (laparoscopic/robotic). People with allergies or intolerance to NSAIDs may not participate.Check my eligibility
What is being tested?
The study aims to eliminate opioid prescriptions at discharge after major urologic surgeries. The focus is on whether patients can recover without opioids and avoid the risk of developing a habit or persistent use associated with postoperative pain management.See study design
What are the potential side effects?
Since this trial involves not prescribing opioids, there are no direct side effects from medications being tested. However, participants might experience different levels of postoperative pain managed by alternatives to opioids.
NOPIOiDS Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am having major surgery for urologic cancer, no matter the method.
Select...
I have undergone major surgery for urological cancer.
NOPIOiDS Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 30 days
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~30 days
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
All opioids prescriptions within 30 days of surgery
Opioids
Secondary outcome measures
Contact with healthcare facilities
Post-operative pain after discharge
Satisfaction score during home recovery
NOPIOiDS Trial Design
1Treatment groups
Experimental Treatment
Group I: No opioids prescriptions at dischargeExperimental Treatment1 Intervention
Patients will receive non-opioid analgesia, mostly over the counter, medications such as acetaminophen or ibuprofen. Opioids may be prescribed if the patients experience break through pain and call the office.
Find a Location
Who is running the clinical trial?
Albany Medical CollegeLead Sponsor
91 Previous Clinical Trials
11,147 Total Patients Enrolled
Badar Mian, MDPrincipal Investigator - Albany Medical College
Community Care Physicians, Pc
Allama Iqbal Medical College (Medical School)
Va Comwlth University McV School Medicine (Residency)
1 Previous Clinical Trials
398 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am having major surgery for urologic cancer, no matter the method.I have undergone major surgery for urological cancer.
Research Study Groups:
This trial has the following groups:- Group 1: No opioids prescriptions at discharge
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
What is the scope of this research experiment in terms of participants?
"Indeed, the information on clinicaltrials.gov indicates that this trial is currently open to recruitment. It was initially posted on December 15th 2018 and last updated June 14th 2022 with a goal of enrolling 350 patients from 1 site."
Answered by AI
Is an enrollment period still open for this experiment?
"Affirmative. According to clinicaltrials.gov, this medical research project - which was initially posted in December 2018 - is actively recruiting participants. 350 individuals are required from one trial site."
Answered by AI
Share this study with friends
Copy Link
Messenger